WebRosuvastatin, a statin indicated for patients with primary hypercholesterolemia, mixed dyslipidemia and familial hypercholesterolemia, is well tolerated by most patients. Its most common adverse effects are gastrointestinal derangement, muscle aches and hepatitis. One rare complication of statin treatment is severe thrombocytopenia. WebApr 10, 2024 · Lipitor (Atorvastatin) ... Low blood platelet count (thrombocytopenia) ... which usually doesn’t cause any symptoms, means that you can potentially pass the gene to any children you have ...
Thrombocytopenia: Symptoms, Stages & Treatment - Cleveland Clinic
WebRationale: Familial hypercholesterolemia (FH) is caused by mutations in genes involved in low-density lipoprotein cholesterol (LDL-C) metabolism, including those for pro-protein convertase subtilisin/kexin type 9 (PCSK-9). The effect of PCSK-9 inhibition on the plasma lipidome has been poorly explored. Objective: Using an ultra-high-performance liquid … WebApr 1, 2024 · inability to have or keep an erection. increased body movements. increased sensitivity of the eyes to light. increased sensitivity to touch or pain. increased thirst. increased urination. loss of bladder control. loss of sexual ability, drive, or desire. menstrual bleeding occurring earlier or lasting longer than usual. northern cities in alaska
Transaminitis: Symptoms, Causes, and Treatment - Healthline
WebThe patient developed a petechial rash and bleeding from gums within a week of starting atorvastatin, and his platelet count dropped to … WebMar 1, 2008 · To explore the effect of short-term cholesterol-lowering treatment with atorvastatin on erythrocyte sodium–lithium countertransport (Na+/Li+ ... 140–159 mm Hg and/or diastolic BP, 90–99 mm Hg) and primary hypercholesterolemia low-density lipoprotein (LDL) cholesterol >4.1 mmol/l and triglycerides (TG) <2.8 mmol/l), group B of … WebNov 16, 2008 · While absolute lymphocyte (p=0.003) and platelet counts (p=0.001) were decreased with atorvastatin treatment, absolute monocyte count increased (p=0.002). On flow-cytometric examination, the expressions of CD14 (p=0.015) and CD19 (p=0.039) on lymphocytes were decreased with atorvastatin. northern cities in ca